Nuwellis Inc NUWE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:55 PM EDT
0.25UNCH (UNCH)
Volume
143,211
Close
0.2482quote price arrow down-0.0041 (-1.625%)
Volume
2,078,168
52 week range
0.12 - 3.83
Loading...
  • Open0.2563
  • Day High0.2599
  • Day Low0.2364
  • Prev Close0.2523
  • 52 Week High3.83
  • 52 Week High Date06/20/23
  • 52 Week Low0.12
  • 52 Week Low Date05/01/24

Key Stats

  • Market Cap4.48M
  • Shares Out18.05M
  • 10 Day Average Volume26.67M
  • Dividend-
  • Dividend Yield-
  • Beta0.43
  • YTD % Change-57.27

KEY STATS

  • Open0.2563
  • Day High0.2599
  • Day Low0.2364
  • Prev Close0.2523
  • 52 Week High3.83
  • 52 Week High Date06/20/23
  • 52 Week Low0.12
  • 52 Week Low Date05/01/24
  • Market Cap4.48M
  • Shares Out18.05M
  • 10 Day Average Volume26.67M
  • Dividend-
  • Dividend Yield-
  • Beta0.43
  • YTD % Change-57.27

RATIOS/PROFITABILITY

  • EPS (TTM)-8.30
  • P/E (TTM)-0.03
  • Fwd P/E (NTM)-0.18
  • EBITDA (TTM)-16.176M
  • ROE (TTM)-273.98%
  • Revenue (TTM)8.895M
  • Gross Margin (TTM)57.41%
  • Net Margin (TTM)-202.97%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nuwellis Inc

 

Profile

MORE
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including...
John Erb
Non-Executive Chairman of the Board
Nestor Jaramillo Jr.
President, Chief Executive Officer, Director
Robert Scott
Chief Financial Officer
Address
12988 Valley View Rd
Eden Prairie, MN
55344-3657
United States